Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cisbio Bioassays, now a brand under Revvity, is a leading global provider of specialized reagents and assay kits for the life sciences industry. The company is renowned for its proprietary Homogeneous Time-Resolved Fluorescence (HTRF) technology, which enables sensitive and robust screening of biological interactions in a no-wash format. Their extensive product portfolio supports drug discovery across various therapeutic areas, including oncology, immunology, and metabolic diseases, by providing tools to study GPCRs, kinases, and protein-protein interactions. Cisbio's solutions are utilized by pharmaceutical companies and academic researchers worldwide to streamline high-throughput screening and lead optimization workflows. Headquartered in Codolet, France, the company continues to innovate in the field of cellular assays and biomarker detection.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cisbio International.